Results 111 to 120 of about 503,141 (263)

The Turkish Adaptation of the Green Motivation Scale and The Effect of the Green Organizational Climate on Green Motivation

Istanbul Management Journal
Today, where the concept of green gains increasing importance, why organizations want to exhibit green behaviors or what motivates them to act green is an important area of research.
Ali Erbaşı, Serap Kalfaoğlu
doaj   +1 more source

Romanian Version of the Oral Health Values Scale: Adaptation and Validation. [PDF]

Medicina (Kaunas), 2022
Balgiu BA, Sfeatcu R, Mihai C, Lupușoru M, Bucur MV, Tribus L.   +5 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Increasing Danger in Business After the Pandemic: Adaptation of the Quiet Quitting Scale to Turkish

Istanbul Business Research
The awareness created by COVID-19 in people has caused a difference in their thoughts about work-life balance. People who experienced remote working with the idea that they understood the meaning and importance of life better began to resign in this ...
Tayfun Arar, Gülşen Yurdakul
doaj   +1 more source

Flourishing Scale: Adaptation and Evidence of Validity in a Chilean High School Context. [PDF]

Front Psychol, 2022
Carmona-Halty M, Marín-Gutierrez M, Mena-Chamorro P, Sepulveda-Páez G, Ferrer-Urbina R.   +4 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

The Quality of Carer-Patient Relationship Scale: Adaptation and Validation into Portuguese. [PDF]

Int J Environ Res Public Health, 2021
Silva R, Bobrowicz-Campos E, Santos-Costa P, Gil I, Neves H, Apóstolo J.   +5 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Spanish version of the Frontotemporal Dementia Knowledge Scale: adaptation and validation. [PDF]

Arq Neuropsiquiatr, 2022
Guimet NM, Calandri IL, Bagnati PM, Wynn M, Allegri RF.   +4 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source